Found: 32
Select item for more details and to access through your institution.
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.
- Published in:
- Chinese Journal of Lung Cancer, 2010, v. 13, n. 3, p. 171, doi. 10.3779/j.issn.1009-3419.2010.03.15
- By:
- Publication type:
- Article
Practical Value of Molecular Pathology in Stage I-III Lung Cancer: Implications for the Clinical Surgeon.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 11, p. 3459, doi. 10.1245/s10434-015-4704-z
- By:
- Publication type:
- Article
Phase II Study of the GI-4000 KRAS Vaccine After Curative Therapy in Patients With Stage I-III Lung Adenocarcinoma Harboring a KRAS G12C, G12D, or G12V Mutation.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 405, doi. 10.1016/j.cllc.2014.06.002
- By:
- Publication type:
- Article
Absence of Biomarker-Driven Treatment Options in Small Cell Lung Cancer, and Selected Preclinical Candidates for Next Generation Combination Therapies.
- Published in:
- Frontiers in Pharmacology, 2021, v. 12, p. 1, doi. 10.3389/fphar.2021.747180
- By:
- Publication type:
- Article
Cisplatin Versus Carboplatin for Patients With Metastatic Non-Small-Cell Lung Cancer—An Old Rivalry Renewed.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2007, v. 99, n. 11, p. 828, doi. 10.1093/jnci/djk222
- By:
- Publication type:
- Article
Phase 1 Trial of Everolimus and Gefitinib in Patients With Advanced Nonsmall-Cell Lung Cancer.
- Published in:
- Cancer (0008543X), 2007, v. 110, n. 3, p. 599, doi. 10.1002/cncr.22816
- By:
- Publication type:
- Article
A phase I/II study of weekly high‐dose erlotinib in previously treated patients with nonsmall cell lung cancerPresented in part at the 2004 American Society of Clinical Oncology Meeting, New Orleans, Louisiana, June 5–8, 2004.
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 5, p. 1034
- By:
- Publication type:
- Article
Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma.
- Published in:
- Cancer (0008543X), 2005, v. 104, n. 10, p. 2149
- By:
- Publication type:
- Article
Imatinib mesylate lacks activity in small cell lung carcinoma expressing c‐kit protein: A Phase II clinical trial.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 10, p. 2128
- By:
- Publication type:
- Article
Economic and social changes among distressed family caregivers of lung cancer patients.
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 3, p. 819, doi. 10.1007/s00520-012-1585-6
- By:
- Publication type:
- Article
Thoracic nuclear protein in testis (NUT) carcinoma: expanded pathological spectrum with expression of thyroid transcription factor‐1 and neuroendocrine markers.
- Published in:
- Histopathology, 2021, v. 78, n. 6, p. 896, doi. 10.1111/his.14306
- By:
- Publication type:
- Article
Cooperation of p53 loss of function and v-Ha- ras in transformation of mouse keratinocyte cell lines.
- Published in:
- Molecular Carcinogenesis, 1998, v. 21, n. 1, p. 50, doi. 10.1002/(SICI)1098-2744(199801)21:1<50::AID-MC7>3.0.CO;2-T
- By:
- Publication type:
- Article
Phase II study of docetaxel and vinorelbine as adjuvant chemotherapy for resected non-small cell lung cancers.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 4, p. 931, doi. 10.1007/s00280-013-2263-1
- By:
- Publication type:
- Article
Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 72, n. 2, p. 453, doi. 10.1007/s00280-013-2219-5
- By:
- Publication type:
- Article
A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A phase 2 study of weekly albumin-bound paclitaxel (Abraxane) given as a two-hour infusion.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 68, n. 5, p. 1331, doi. 10.1007/s00280-011-1621-0
- By:
- Publication type:
- Article
A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 65, n. 5, p. 833, doi. 10.1007/s00280-009-1088-4
- By:
- Publication type:
- Article
A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 4, p. 467, doi. 10.1007/s00280-006-0286-6
- By:
- Publication type:
- Article
A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2006, v. 57, n. 5, p. 671, doi. 10.1007/s00280-005-0080-x
- By:
- Publication type:
- Article
A phase I trial of perillyl alcohol in patients with advanced solid tumors.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
- Published in:
- PLoS ONE, 2016, v. 11, n. 1, p. 1, doi. 10.1371/journal.pone.0146063
- By:
- Publication type:
- Article
Non-Small Cell Lung Cancer in the Era of Personalized Medicine: Molecular Tests that Matter.
- Published in:
- Rhode Island Medical Journal, 2020, v. 103, n. 3, p. 28
- By:
- Publication type:
- Article
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and safety of bevacizumab in active brain metastases from non-small cell lung cancer.
- Published in:
- Journal of Neuro-Oncology, 2010, v. 100, n. 3, p. 443, doi. 10.1007/s11060-010-0200-2
- By:
- Publication type:
- Article
Management of patients with resectable stage IIIA (N2) NSCLC.
- Published in:
- Journal of Surgical Oncology, 2006, v. 94, n. 7, p. 551, doi. 10.1002/jso.20649
- By:
- Publication type:
- Article
Revisiting MET: Clinical Characteristics and Treatment Outcomes of Patients with Locally Advanced or Metastatic, MET‐Amplified Esophagogastric Cancers.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. e1691, doi. 10.1634/theoncologist.2020-0274
- By:
- Publication type:
- Article
Adjuvant Therapy for a 3.9-cm Adenocarcinoma of the Lung. CON.
- Published in:
- Oncologist, 2013, v. 18, n. 12, p. 1259, doi. 10.1634/theoncologist.2013-0297.
- By:
- Publication type:
- Article
Adjuvant Therapy for a 3.9-cm Adenocarcinoma of the Lung. PRO.
- Published in:
- Oncologist, 2013, v. 18, n. 12, p. 1259, doi. 10.1634/theoncologist.2013-0297
- By:
- Publication type:
- Article
Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-51722-x
- By:
- Publication type:
- Article
Benefits and harms of CT screening for lung cancer: a systematic review.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Benefits and Harms of CT Screening for Lung Cancer. A Systematic Review.
- Published in:
- JAMA: Journal of the American Medical Association, 2012, v. 307, n. 22, p. 2418, doi. 10.1001/jama.2012.5521
- By:
- Publication type:
- Article
Preclinical Synergistic Combination Therapy of Lurbinectedin with Irinotecan and 5-Fluorouracil in Pancreatic Cancer.
- Published in:
- Current Oncology, 2023, v. 30, n. 11, p. 9611, doi. 10.3390/curroncol30110696
- By:
- Publication type:
- Article